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The process of eukaryotic translation initiation can be regulated by a highly conserved mechanism involving the phosphorylation of the
translation initiation factor eIF2 on the a subunit. This mechanism is recognized as an efficient step in the host antiviral response. Vaccinia
virus (VV), like many other viruses, encodes proteins to overcome this inhibitory process. The C-terminus of the vaccinia virus E3L is known
to bind to double-stranded RNA (dsRNA) thereby sequestering the activator of this antiviral response. In this report, the N-terminus of E3L
was found to be required for the additional regulation of eIF2a phosphorylation. This phosphorylation event did not lead to a global
shutdown in protein synthesis. Because the N-terminus of E3L is required for full viral pathogenesis in mice, these results suggest an
alternative role of eIF2a phosphorylation in regulating viral replication.
D 2004 Elsevier Inc. All rights reserved.Keywords: PKR; Vaccinia virus; C-terminal domain
Introduction the a subunit of eIF2. Phosphorylated eIF2a has an in-In the process of eukaryotic translation initiation, the
methionyl initiator tRNA is transferred to the 40S ribo-
somal subunit in a ternary complex consisting of Met-
tRNAi
Met, the heterotrimeric initiation factor 2 (eIF2), and
GTP. The resulting 43S preinitiation complex binds to the
mRNA, scans for the AUG start codon, and leads to the
hydrolysis of the GTP bound to eIF2 after base pairing
between Met-tRNAi
Met and AUG. eIF2-GDP is subsequent-
ly released and the 60S ribosomal subunit binds to form the
80S initiation complex. The released eIF2-GDP is inactive
for binding additional Met-tRNAi
Met and must be recycled
back to eIF2-GTP by the guanine nucleotide exchange
factor eIF2B before it can be used in the formation of
another ternary complex (Hinnebusch, 2000; Krishnamoor-
thy et al., 2001).
The process of translation initiation can be controlled by
a conserved mechanism involving the phosphorylation of0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: bjacobs@asu.edu (B.L. Jacobs).creased affinity for eIF2B, and this high affinity binding
prevents the recycling process (Kimball, 1999; Krishna-
moorthy et al., 2001). Because eIF2 is typically found in
excess to eIF2B, phosphorylation of only a small fraction of
eIF2a can effectively inhibit continued initiation of transla-
tion (Hinnebusch, 2000; Krishnamoorthy et al., 2001).
The phosphorylation of eIF2a is a critical control point
in the regulation of protein synthesis under various stress
conditions such as viral infection, apoptosis, cell transfor-
mation, nutritional starvation, heme deprivation, and im-
proper protein folding (Kimball, 1999). Four different eIF2a
kinases have been identified in mammalian cells including
the double-stranded RNA (dsRNA)-dependent protein ki-
nase (PKR), the endoplasmic reticulum PKR-like kinase
(PERK), the erythroid cell heme-regulated kinase (HRI),
and the amino acid starvation kinase (GCN2) (Chen, 2000;
Hinnebusch, 2000; Kaufman, 2000; Ron and Harding,
2000). In response to many viral infections, PKR becomes
activated, phosphorylates eIF2a, and prevents viral replica-
tion by blocking translation initiation. In addition to the
regulation of translation, PKR has also been shown to
participate in the induction of apoptosis and the inhibition
of cell proliferation (Kaufman, 2000).
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induction of PKR expression (Kaufman, 2000; Meurs et al.,
1990). Stimulation of PKR activity in response to viral
infection involves binding of PKR to dsRNA synthesized
during most viral infections. Activation of PKR after
dsRNA binding appears to require dimerization and subse-
quent autophosphorylation (Gunnery and Mathews, 1998).
Subcellularly, the majority of PKR is present bound to
ribosomes, but a smaller fraction is also present free in the
cytosol and in the nucleus (Jeffrey et al., 1995; Langland
and Jacobs, 1992; Takizawa et al., 2000). Similarly, eIF2
has also been identified in both the cytoplasmic and nuclear
cellular fractions (DeGarcia et al., 1997; Goldstein et al.,
1999; Lobo et al., 1997, 2000; Martin et al., 1993; Ting et
al., 1998). These data may suggest alternative roles of PKR
and eIF2 based on subcellular localization.
Replication of vaccinia virus (VV) is resistant to the
antiviral effects associated with the PKR response (Beattie
et al., 1995; Chang and Jacobs, 1993; Chang et al., 1995;
Davies et al., 1993). The VV E3L gene encodes two
proteins, p25 and p20, that bind to and sequester dsRNA
synthesized during viral replication (Chang and Jacobs,
1993; Shors et al., 1997). This binding acts to ‘mask’ the
dsRNA thereby preventing recognition and subsequent
activation of PKR (Chang et al., 1992). Deletion of the
E3L gene from VV (VVDE3L) results in a virus that is IFN
sensitive in RK13 cells and has a restricted host range
phenotype where replication is not permissive in HeLa cells
(Langland and Jacobs, 2002). The full-length E3L protein is
190 amino acids in length with a highly conserved dsRNA-
binding domain on the carboxyl-half (Chang and Jacobs,
1993; St. Johnston et al., 1992). The dsRNA-binding
domain is required for the IFN-resistant and broad host
range phenotype associated with the virus. In HeLa cells,
VVDE3L leads to activation of PKR and eIF2a phosphor-
ylation with a consequent inhibition in global protein
synthesis (Langland and Jacobs, 2002).
The amino-terminal half of the E3L protein is highly
conserved among distantly related poxviruses, but the
functional role of this region has been less well character-
ized. VV encoding an amino-terminal deletion mutant of
E3L (VV-E3LD83N) remains IFN-resistant and has a broad
host range phenotype similar to wtVV (Chang et al., 1995;
Shors et al., 1998). In the mouse model, however, both the
N-terminus and C-terminus of E3L are required for full
pathogenesis (Brandt and Jacobs, 2001). Biochemically, the
N-terminal domain has been suggested to be involved in the
direct inhibition of PKR activation, nuclear localization, and
Z-DNA binding (Brandt and Jacobs, 2001; Kim et al., 2003;
Romano et al., 1998; Yuwen et al., 1993).
In this report, the role of the N-terminus of E3L was
further investigated. In HeLa cells, VVE3LD83N inhibited
eIF2a phosphorylation at the initial-late phase of infection,
but at later times, high levels of eIF2a phosphorylation were
observed. This effect on eIF2a phosphorylation was not
detected in cells infected with wtVV. Unlike infection withVVDE3L, the phosphorylation of eIF2a following infection
with VVE3LD83N did not lead to any significant reduction
in global protein synthesis levels or in viral replication titers.
However, there was a dramatic inhibition in the synthesis of
secreted viral proteins at the delayed-late phase of infection
with VVE3LD83N. These results suggest an alternative
activity associated with the observed eIF2a phosphorylation.Results
The E3L gene products of VV are required for the IFN-
resistant and broad host range phenotype associated with the
virus (Chang and Jacobs, 1993; Chang et al., 1995; Shors et
al., 1997). VV constructs deleted of the E3L gene VVDE3L
have been shown previously to lead to activation of PKR and
eIF2a phosphorylation (Langland and Jacobs, 2002). To
further define the role of the amino terminus of E3L, HeLa
cells were infected with VV mutants encoding deletions in
the N-terminus. These constructs, VVE3LD37N and
VVE3LD83N, neither disrupt the dsRNA-binding affinity
of E3L nor do they affect protein stability (Chang and Jacobs,
1993; data not shown). When total cell lysates were assayed
for eIF2a phosphorylation using antiserum specific for
phosphorylated eIF2a, mock and wtVV-infected cells
showed no detectable eIF2a phosphorylation (Fig. 1, lanes
A and B). As expected, infection with VVDE3L resulted in
eIF2a phosphorylation at the initial-late phase and continu-
ing until the delayed-late phase of infection (Fig. 1, lane C).
Infection with VVE3LD37N and VVE3LD83N resulted in
eIF2a phosphorylation only at the delayed-late phase of
infection relative to VVDE3L, beginning around 9 h postin-
fection (HPI; Fig. 1, lanes D and E). The presence of eIF2a
phosphorylation during the replication of viruses expressing
N-terminal mutations in E3L could be due to lower amounts
of E3L protein leading to reduced sequestering of dsRNA.
However, when analyzed, the synthesis, protein turnover,
steady-state levels, and dsRNA affinity of wt E3L compared
to the N-terminally deleted E3Ls were essentially identical
(Chang and Jacobs, 1993, data not shown). This suggests that
the eIF2a phosphorylation observed with these viruses is due
to the loss of a functional role in the N-terminus of E3L.
When HeLa cells were pretreated with interferon, wtVV
infection still inhibited any eIF2a phosphorylation (Fig. 1,
lane F). This was as expected due to the IFN resistance
observed with this virus. When IFN-treated cells were
infected with VVDE3L, high levels of eIF2a phosphoryla-
tion similar to that of untreated cells were observed (Fig. 1,
lane G). IFN-treated cells infected with VVE3LD37N and
VVE3LD83N produced unexpected results. Infection with
these viruses led to no detectable eIF2a phosphorylation at
any time postinfection (Fig. 1, lanes H and I).
All extracts tested were assayed for levels of total eIF2a
to confirm that phosphorylation differences were not due to
differences in the amount of eIF2a protein. No significant
differences in eIF2a protein levels were observed in any of
Fig. 2. Ratio of total eIF2a relative to phosphorylated eIF2a during VV
infection. Cell lysates from Fig. 1 were additionally probed with antiserum to
eIF2a (data not shown). Results from this Western blot and the blot from
Fig. 1 were analyzed by densitometric analysis. The relative ratio of total
eIF2a to phosphorylated eIF2awas calculated and results graphed as shown.
Fig. 1. Regulation of eIF2a phosphorylation by the VV E3L protein. HeLa cells were mock (lanes A–E) or pretreated with IFN (lanes F– I). Following this
treatment, cells were mock infected (lane A), or infected with wtVV (lanes B and F), VVDE3L (lanes C and G), VVE3LD37N (lanes D and H), or
VVE3LD83N (lanes E and I). At the indicated times postinfection, cell lysates were prepared. Proteins from equal numbers of cells were separated by SDS-
PAGE and assayed by Western blot analysis using antiserum specific to the phosphorylated form of eIF2a.
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used to detect total eIF2a and phosphorylated eIF2a was
from different sources, the percentage of eIF2a phosphor-
ylated could not be determined. However, the relative ratio
of total eIF2a to phosphorylated eIF2a between different
viral infections could be measured. As shown in Fig. 2,
the relative amount of phosphorylated eIF2a observed
with VVDE3L was equivalent to that observed with
VVE3LD37N and VVE3LD83N at 9 HPI. Because all
extracts contained the same amount of total protein and
total eIF2a, these results suggest that similar percentages of
eIF2a were phosphorylated during infection with VVDE3L
as compared to VVE3LD37N or VVE3LD83N.
Virus infection has been shown to modulate the activity
of at least two different eIF2a kinases, PKR and PERK
(Gale and Katze, 1998; Jordan et al., 2002; Sen, 2001).
Activation of PKR and PERK requires an autophosphory-
lation event (Ron and Harding, 2000; Kaufman, 2000). To
determine which eIF2a kinase was responsible for the
eIF2a phosphorylation observed during infection with
VVE3LD83N, infected cells were radiolabelled with 32P,
immune-precipitated with antiserum to PKR or PERK, and
the amount of 32P incorporated into the protein kinase
determined. Equivalent levels of 32P were incorporated into
PKR in both mock and wtVV-infected cells (Fig. 3A, lanes
A and B). Infection with VVDE3L led to a 2-fold increase in
PKR phosphorylation levels consistent with previous results
(Figs. 3A and B, lane C) (Langland and Jacobs, 2002).
Infection with VVE3LD83N also led to a 2-fold increase in
PKR phosphorylation (Figs. 3A and B, lane D). Levels of
PERK phosphorylation did not vary between mock or any
virally infected cells (Figs. 3A and B, lanes A–D). How-ever, treatment of cells with , which is known to lead to
phosphorylation and activation of PERK (Harding et al.,
2000), led to a 3-fold increase in PERK phosphorylation
levels, verifying that phosphorylation of PERK could be
detected (Figs. 3A and B, lane E). These results suggest that
the eIF2a phosphorylation observed during infection with
the E3L N-terminal deletion constructs was due to PKR
activity.
PKR activation during viral infection has typically been
shown to be due to the presence of free dsRNA (Kaufman,
Fig. 4. Regulation of OAS activity during VV infection. HeLa cells were
mock infected (lanes A and E), or infected with wtVV (lanes B and F),
VVDE3L (lanes C and G), or VVE3LD83N (lanes D and H). At 12 HPI
(lanes A–D) or 18 HPI (lanes E–H), cells were harvested and total RNA
extracts prepared. RNA samples from equal numbers of cells were
separated on a 1.8% agarose gel and visualized by staining with ethidium
bromide. The positions of the 18S and 28S rRNAs are shown. rRNA
degradation products are marked with an *.
Fig. 3. eIF2a kinase activation during VV infection. HeLa cells were
radiolabelled with [32P]orthophosphate and mock infected (lane A), or
infected with wtVV (lanes B and E), VVDE3L (lane C), or VVE3LD83N
(lane D). Lane E was additionally treated with thapsigargin 0.5 h before
harvest. At 12 HPI, cells were harvested, lysed, and PKR or PERK
immunoprecipitated using antiserum specific to each kinase. Immunopre-
cipitated proteins from equal numbers of cells were separated by SDS-PAGE
and visualized by autoradiography. The autoradiogram is shown in panel A.
Densitometric quantitation of the autoradiogram is shown in panel B.
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Other antiviral pathways, including the 2V5Voligoadenylate
synthetase pathway (OAS), have also been shown to be
activated in the presence of dsRNA (Carroll et al., 1997;
Kerr and Brown, 1978). Because the eIF2a phosphorylation
observed during infection with VVD83N appeared to be due
to PKR, activation of the OAS pathway during VV infection
was determined. Activation of OAS requires binding to
dsRNA and leads to an inhibition in protein synthesis by
the degradation of mRNA and rRNA. Typical measurements
of OAS activity include the isolation of total cellular RNA
and determining rRNA degradation levels (Carroll et al.,
1997; Kerr and Brown, 1978). As shown in Fig. 4, mock
and wtVV infection of HeLa cells did not lead to any
degradation of rRNA (lanes A and E, and B and F,
respectively). At 12 HPI, rRNA degradation was observed
with VVDE3L (Fig. 4, lane C) and to a minor extent with
VVE3LD83N (Fig. 4, lane D). This degradation is indica-
tive of that previously observed with VVDE3L due to OAS
activity (Langland and Jacobs, 2002). By 18 HPI, the levelsof rRNA degradation with VVE3LD83N increased to in-
tensities similar to that of VVDE3L (Fig. 4, compare lanes
G and H). These results suggest that the N-terminus of E3L
may be regulating the level of free dsRNA present at the
delayed-late phase of infection that is capable of activating
both PKR and OAS antiviral enzymes.
As shown here and previously, infection with VVDE3L
leads to the phosphorylation of eIF2a (Langland and
Jacobs, 2002). Also shown previously, a shutdown in global
protein synthesis occurs after this phosphorylation event
(Langland and Jacobs, 2002). In agreement with these data,
infection of HeLa cells with VVDE3L led to a complete
shutdown in protein synthesis as early as 3 HPI (data not
shown) and continuing through 12 HPI (Fig. 5, lane C).
Infection with wtVV demonstrated a switch from cellular to
viral protein synthesis and normal levels of viral translation
(Fig. 5, compare lanes B and A). Despite high levels of
eIF2a phosphorylation at 12 HPI with VVE3LD37N or
VVE3LD83N (see Fig. 1), the protein synthesis pattern and
levels of translation are similar to that of wtVV (Fig. 5,
lanes D and E). Pretreatment of cells with IFN did not alter
the translation patterns from that observed in the absence of
IFN (Fig. 5, lanes F–I).
These data suggest that the eIF2a phosphorylation
observed at the delayed-late phase of infection with
VVE3LD37N and VVE3LD83N does not lead to a subse-
quent block in bulk protein synthesis. This result was
unexpected due to the high levels of eIF2a phosphoryla-
tion observed upon infection with these viruses. VV is
known to regulate the host immune response by the
synthesis and secretion of various virokines (Kotwal,
2000). To determine if the eIF2a phosphorylation observed
with VVE3LD83N could inhibit a specific class of pro-
teins, the synthesis of VV-secreted proteins was measured
by radiolabelling infected cells with [35S]-methionine and
Fig. 6. VV regulation of secretory protein synthesis. HeLa cells were mock
infected (lane A), or infected with wtVV (lane B), VVDE3L (lane C), or
VVE3LD83N (lane D). From 3–6 and 9–12 HPI, cells were radiolabelled
with [35S]-methionine. Culture supernatants were collected and secreted
proteins concentrated by acid precipitation. Protein concentrations were
determined by BCA analysis and equal protein amounts were separated by
SDS-PAGE. Radiolabelled proteins were visualized by autoradiography.
Fig. 5. Protein synthesis in VV-infected cells. HeLa cells were mock (lanes
A–E) or pretreated with IFN (lanes F– I). Treated cells were then mock
infected (lane A), or infected with wtVV (lanes B and F), VVDE3L (lanes C
and G), VVE3LD37N (lanes D and H), or VVE3LD83N (lanes E and I). At
12 HPI, cells were radiolabelled with [35S]-methionine for 0.5 h. Cell
lysates were prepared, proteins from equal numbers of cells were separated
by SDS-PAGE, and radiolabelled proteins visualized by autoradiography.
Representative viral proteins are marked with an *.
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As shown in Fig. 6, wtVV induced the synthesis of various
secreted proteins at the initial-late and delayed-late phases
of infection (compare lane A to lane B). Along with the
intracellular block in protein synthesis observed with
VVDE3L, an inhibition in secretory protein synthesis
was also observed (Fig. 6, lane C). Upon infection with
VVE3LD83N, secretory protein synthesis was indistin-
guishable from wtVV at the initial-late phase (Fig. 6, lane
D), but at the delayed-late phase, reduced levels of
secreted proteins were observed compared to wtVV (Fig.
6, lane D). In wtVV infection at the delayed-late phase (9–
12 HPI), a single major translation product was observed
(Fig. 6, lane B). Radiolabelled protein sequencing of the
first 12 amino acids of this protein using 3H-leucine
suggested that this protein encodes a leucine at residues
9, 11, and 12 (data not shown). Of the known VV
secretory proteins, only the viral complement binding
protein VCP would have this radiolabelled sequence and
is of the appropriate molecular weight (Kotwal and Moss,
1988).
To confirm the inhibition of VCP protein synthesis
upon infection with VVE3LD83N, an antiserum specific
to VCP was utilized. Western blot analysis of total cell
lysates demonstrated that at the initial-late phase of
infection, VCP levels are equivalent between wtVV and
VVE3LD83N (Fig. 7, lanes B and D, respectively).
However, at later times postinfection, VCP levels are
significantly reduced in VVE3LD83N-infected cells as
compared to wtVV-infected cells (Fig. 7, lanes J and
H, respectively). These results suggest that infection withVVE3LD83N does not inhibit the secretory process of
VCP, but does alter VCP intracellular levels likely by
inhibiting VCP protein synthesis.
To determine if the eIF2a phosphorylation observed with
VVE3LD83N may be affecting additional steps in the virus
life cycle, levels of intracellular and extracellular infectious
virus were determined. VV maturation results in the forma-
tion of infectious virions present intracellularly and fully
processed extracellular forms. Maturation is a complex
process involving acquisition of unit membranes from the
intermediate compartment of the host cell and enwrapment
with trans-Golgi cisternae (Moss, 1990; Ulaeto et al., 1995).
Previous growth studies on VV have not observed any
differences between wtVV and VVE3LD83N (Chang et
al., 1995; Shors et al., 1998). However, these assays
measured only intracellular viral levels. In agreement with
this, no significant differences were observed in intracellular
virus levels when growth analysis was performed using
wtVV and VVE3LD83N, whereas no replication of
VVDE3L could be detected (data not shown). When viral
levels were determined from the culture supernatant, no
significant differences were observed between wtVV and
VVE3LD83N, suggesting extracellular viral release was not
affected by the eIF2a phosphorylation observed (data not
shown).
Because the N-terminal domain of E3L has previously
been shown to be required for the full pathogenesis of
Fig. 7. VV regulation of intracellular VCP levels. HeLa cells were mock infected (lane A), or infected with wtVV (lanes B, E, and H), VVDE3L (lanes C, F,
and I), or VVE3LD83N (lanes D, G, and J). At the indicated times postinfection, total cell lysates were prepared. Protein from equal numbers of cells were
separated by SDS-PAGE and assayed by Western blot analysis using antiserum specific to VCP.
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pathogenesis was investigated. wtVV and VVE3LD83N
replicate to equivalent high titers in the nasal tissue of
infected mice, whereas replication of VVDE3L is severe-
ly inhibited (Brandt and Jacobs, unpublished observa-
tions). Duplicate mice were infected intranasally with
wtVV, VVDE3L, or VVE3LD83N, and nasal turbinates
harvested 5 days postinfection. Total cell lysates were
prepared and assayed for levels of eIF2a phosphoryla-
tion. As shown in Fig. 8, high levels of eIF2a phos-
phorylation were detected in mice infected with
VVE3LD83N (lanes D and H), but only minor amounts
of phosphorylation were observed in either mock (lanes
A and E) or wtVV-infected mice (lanes B and F). In
mice infected with VVDE3L, no phosphorylation was
observed in one mouse (lane C) and slight phosphoryla-
tion was detected in the other (lane G). The presence of
more eIF2a phosphorylation in VVE3LD83N-infected
mice as compared VVDE3L-infected mice was not unex-
pected because VVDE3L replicates poorly in nasal tissue
of infected mice (Brandt and Jacobs, 2001).Fig. 8. VV regulation of eIF2a phosphorylation in infected mice. Duplicate mice w
VVDE3L (lanes C and G), or VVE3LD83N (lanes D and H). At 5 days postin
concentrations were determined by BCA analysis and equal protein amounts w
antiserum specific to the phosphorylated form of eIF2a.Discussion
Viruses encode a variety of mechanisms to inhibit the
host antiviral response (Gale and Katze, 1998; Sen, 2001).
Two of the most well characterized antiviral pathways
involve the PKR and OAS systems. Because activation of
both of these pathways involves the presence of dsRNA,
many viral inhibitors act to sequester and ‘mask’ the dsRNA
activator. Another common theme to virally encoded inhib-
itors involves proteins that directly bind to PKR and block
activation. The VV E3L protein has been well characterized
as functioning as a dsRNA-binding protein preventing PKR
and OAS recognition of dsRNA (Chang and Jacobs, 1993;
Langland and Jacobs, 2002). The C-terminal region of E3L
contains a conserved dsRNA-binding domain found in
many dsRNA-binding proteins, including PKR (St. John-
ston et al., 1992). Mutations in this domain that reduce
dsRNA-binding affinity no longer block PKR activation,
and viral constructs encoding these mutations are IFN
sensitive and have a limited host range (Chang and Jacobs,
1993; Langland and Jacobs, 2002).ere mock infected (lanes A and E), or infected with wtVV (lanes B and F),
fection, nasal turbinates were harvested and cell lysates prepared. Protein
ere separated by SDS-PAGE and assayed by Western blot analysis using
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terized. Biochemical studies on this domain suggest it is
involved in nuclear localization, Z-DNA binding, and direct
PKR interaction (Brandt and Jacobs, 2001; Kim et al., 2003;
Romano et al., 1998; Yuwen et al., 1993). Deletion of this
domain has a dramatic affect on pathogenesis in mice.
Previous studies demonstrated that both the C-terminus
and N-terminus of E3L are required for full pathogenesis,
with an N-terminal deletion mutant having a 1000-fold
reduction in intranasal LD50 (Brandt and Jacobs, 2001).
Deletion of the N-terminus of E3L does not appear to affect
viral replication in cells in culture. Infection of HeLa cells
with VVE3LD83N does not alter viral protein synthesis
levels or viral assembly and release. By all standard repli-
cation assays, this virus appears completely wild type in
cultured cells. With the use of an antiserum that specifically
recognizes the phosphorylated form of eIF2a, biochemical
differences between wtVV and VVE3LD83N were ob-
served. Infection of HeLa cells with these viruses demon-
strated that the N-terminus of E3L was required to inhibit
protein kinase activity leading to the phosphorylation of
eIF2a at the delayed-late phase of infection. This eIF2a
phosphorylation event appeared to occur via the PKR
pathway and likely involves the presence of free dsRNA
because activation of the OAS pathway occurred as well. It
is possible that as VV replication reaches later times,
dsRNA continues to accumulate beyond levels that can be
sequestered by the dsRNA binding activity associated with
the C-terminus of E3L. As free dsRNA becomes accessible,
PKR binding may occur with subsequent activation and
eIF2a phosphorylation. The N-terminus of E3L may func-
tion to inhibit PKR recognition of this free dsRNA.
Surprisingly, the phosphorylation of eIF2a during
VVE3LD83N infection did not affect cytosolic protein
synthesis. Levels of eIF2a phosphorylation upon infection
with this virus were equivalent to that observed with infec-
tion with VVDE3L, but with VVDE3L infection, a complete
shutoff of protein synthesis was observed. Because minor
amounts of phosphorylated eIF2a typically lead to a block in
translation initiation (Hinnebusch, 2000; Krishnamoorthy et
al., 2001; Williams, 2001), this result is difficult to explain.
Occurring concomitantly with the eIF2a phosphorylation
during VVE3LD83N infection, a reduction in the level of the
viral VCP protein was observed. Because VCP protein
synthesis occurs via the cellular secretory pathway (Kotwal
et al., 1990), one possible explanation is that the eIF2a
phosphorylation observed specifically blocked secretory
protein synthesis without altering protein synthesis on free
ribosomes. The evidence presented suggests that PKR, and
not the ER-associated eIF2a kinase, PERK, was involved in
the eIF2a phosphorylation observed upon infection with
VVE3LD83N. If PKR and the eIF2a phosphorylation ob-
served are responsible for a specific block in secretory
protein synthesis, it would suggest a novel mechanism for
PKR regulation of translation. Romano et al. (1998) have
shown that the N-terminus of E3L does function to directlyinhibit PKR activity in a heterologous yeast system. They
propose that the N-terminus of E3L interacts with the kinase
domain of PKR thereby interfering with some aspect of
kinase function. Our results provide the first evidence to
suggest a role of the N-terminus of E3L to inhibit PKR
activity in a more relevant mammalian model system.
The lack of VCP synthesis is consistent with previous
data regarding VV-reduced pathogenesis in animals. VCP
functions primarily as a modulator of complement activation
by acting as a cofactor for the serine protease factor I that
enzymatically cleaves the a’-chains of C3b and C4b into
inactive fragments (Kotwal et al., 1990; Sahu et al., 1998).
Previous studies have shown that deletion of VCP does not
affect the growth of VV in cells in culture, but VCP
expression does enhance the virulence of the virus in rabbits
and guinea pigs and causes larger lesions when injected
intradermally (Isaacs et al., 1992). The lack of VCP syn-
thesis during the delayed-late phase of infection with
VVE3LD83N could explain the reduced pathogenesis ob-
served in mice when infected with VV encoding N-terminal
mutants of E3L. Kim et al. (2003) have shown that the Z-
DNA binding activity associated with the N-terminus of
E3L directly correlates with increased pathogenesis in mice
after intracranial inoculation. However, recent data suggest
that pathogenesis associated with intranasal inoculation of
VV required additional functions of the N-terminus of E3L
beyond Z-DNA binding (data not shown). This activity of
the N-terminus of E3L may be essential for efficient spread
of the virus from the nasal turbinates to the brain. Because
intranasal inoculation of mice with VVE3LD83N led to a
lack of virus spread to the brain and increased levels of
eIF2a phosphorylation, we suggest that the eIF2a phos-
phorylation induced in the absence of the N-terminus of
E3L may be involved in the observed decrease in viral
pathogenesis.
The lack of translation inhibition even in the presence
of eIF2a phosphorylation could be due to the altered
subcellular distribution of the phosphorylated eIF2. PKR
and several translational initiation factors have been
found to be present in both the cytoplasm and nucleus
of cells (DeGarcia et al., 1997; Goldstein et al., 1999;
Jeffrey et al., 1995; Langland and Jacobs, 1992; Lobo et
al., 1997, 2000; Martin et al., 1993; Takizawa et al.,
2000; Ting et al., 1998; Strudwick and Borden, 2002).
The role of these proteins in the nucleus remains unclear,
but with the eIF2 heterotrimer, a stable complex has been
identified in association with DNA-PK, NF90, and NF45
(Ting et al., 1998). Furthermore, eIF2 is able to bind
both double-stranded and single-stranded DNA cellulose
resins, suggesting that eIF2 may be capable of interacting
with nucleic acid other than RNA (Ting et al., 1998).
The h-subunit of eIF2 encodes a zinc finger and poly-
lysine blocks similar to those identified on proteins
known to regulate transcription (Goldstein et al., 1999).
In another study, it was observed that during post-
ischemic brain reperfusion, there is a dramatic increase
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ly, the phosphorylated eIF2a is found in the cytoplasm,
but at later times, there is an additional accumulation of
phosphorylated eIF2a in the nucleus.
High levels of phosphorylated eIF2a have been identi-
fied in several cell lines and tumor samples without a
subsequent loss in global protein synthesis. In Ehrlich
ascites tumor cells, the soluble S-100 fraction of eIF2a is
predominantly phosphorylated, whereas the ribosome-asso-
ciated form exists mainly in an unphosphorylated state
(Wong et al., 1982). In several malignant cells from patients,
a subcellular redistribution of eIF2a has been observed
(Lobo et al., 2000). In these tumor cells, there is a signif-
icant increase in the percentage of eIF2a in the nucleus and
nucleolus as compared to the cytoplasm (Lobo et al., 2000).
In addition to this redistribution, an increase in the percent-
age of phosphorylated eIF2a is observed. This percentage
reached levels up to 54% of the total eIF2a (Lobo et al.,
2000). This increase in phosphorylation was not accompa-
nied by a decrease in protein synthesis, even though
previous studies have suggested that, in other cell lines,
when 20% of eIF2a is phosphorylated, protein translation is
inhibited (Williams, 2001). Thus, at least with malignant
cells, this phosphorylation may occur without a block in
bulk protein synthesis. A similar phenomenon could explain
the eIF2a phosphorylation without a block in protein
synthesis observed during VVE3LD83N infection. Howev-
er, preliminary experiments using differential centrifugation
suggest that the phosphorylated eIF2a observed during
infection with both VVDE3L and VVE3LD83N was not
localized to the nuclear fraction but instead was only
detected in the microsomal pellet (data not shown).
Several of the known viral inhibitors of PKR are present
in the nucleus of infected cells. Along with the VV E3L
proteins, the reovirus j3 protein, the hepatitis C virus
NS5A protein, the herpes simplex virus g34.5 protein,
and the human herpes virus 8 vIRF-2 protein have all
been shown to localize to the nucleus (Burysek and Pitha,
2001; Cheng et al., 2002; Gale et al., 1997; Kato et al.,
1997; Yue and Shatkin, 1996). During infection with
adenovirus, a redistribution of PKR within the nucleus is
observed (Souquere-Besse et al., 2002), and during infec-
tion with hepatitis y virus, the S-HDAg likely associates
with nuclear PKR and is subsequently phosphorylated
(Chen et al., 2002). Although some of these proteins have
alternative roles in the nucleus, these results may suggest
nuclear PKR as an additional target for these viral proteins.
Unlike wtVV E3L, the E3L protein encoded by
VVE3LD83N remains associated in the cytoplasm of
infected cells (Chang et al., 1995). During wtVV infection,
E3L may translocate to the nucleus to inhibit nuclear PKR
activity.
One other unexpected result obtained during these
experiments was that IFN pretreatment of cells reduced
the level of eIF2a phosphorylation observed upon infection
with VVE3LD83N (Fig. 1). One possible explanation forthis observation may involve the induction and activity
associated with other IFN-induced proteins. Two immuno-
logically related forms of the dsRNA-dependent adenosine
deaminase (ADAR1) have been identified. A longer 150-
kDa form is known to be induced upon IFN treatment and
is localized to the cytoplasm and nucleus. An amino-
terminally truncated 110-kDa form is constitutive
expressed and is found predominantly in the nucleus
(George and Samuel, 1996; Strehblow et al., 2002).
ADAR1 can bind to dsRNA and RNA with secondary
structure and deaminate adenosine residues to inosine
(Bass, 1997). This results in an altered sequence of the
RNA molecule and likely leads to denaturation of the
dsRNA structure. During wtVV infection, E3L likely
sequesters the viral dsRNA preventing recognition by
ADAR1, as well as PKR. Because infection with
VVE3LD83N appears to lead to the synthesis of free
dsRNA, IFN treatment of cells may allow the IFN-induced
form of ADAR1 to bind to and modify this dsRNA.
Depending on the level of modification by ADAR1, the
overall quantity of dsRNA may subsequently be reduced.
This reduction in dsRNA levels may allow full E3L seques-
tering of the remaining dsRNA thereby preventing PKR
activation and eIF2a phosphorylation in VVE3LD83N-
infected IFN-treated cells.
The results presented support a role for the N-terminus of
E3L in regulating PKR activation. Because subsequent
eIF2a phosphorylation does not lead to a global block in
translation, this phosphorylated eIF2a may block translation
of specific mRNAs, like the VCP mRNA. Given the
importance of the N-terminus of E3L in determining path-
ogenesis, regulation of eIF2a phosphorylation at the
delayed-late phase of infection may be an important event
during infection in a whole animal. Because the N-terminus
of E3L is highly conserved among many members of the
poxvirus family, this function of E3L may be critical in the
interaction of poxviruses with their host.Materials and methods
Cells and viruses
HeLa cells were maintained as monolayers in Dulbec-
co’s minimum essential media (D-MEM) supplemented
with 50 Ag/ml gentamicin sulfate and 10% feta1 bovine
serum (Hyclone). Vaccinia virus VC-2 (Copenhagen
strain), designated in this paper as wtVV, was the parent
strain for all viruses used in this study. VV deleted for
E3L (VVDE3L or vP1080) or viruses containing
N-terminal deletions of E3L (VVE3LD37N and
VVE3LD83N) were generated as previously described
(Chang and Jacobs, 1993; Chang et al., 1995; Shors et
al., 1997). For IFN treatment, cells were treated with 100
IU/ml recombinant human a A/D IFN (Hoffman-La
Roche) for 18 h before infection.
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Cell monolayers infected at an MOI = 5 were starved
for methionine at 0.5 h before labelling using methionine-
free D-MEM. After starvation, newly synthesized proteins
were labelled with 50 ACi of [35S]methionine/ml (800 Ci/
mmol) for 30 min. At that time, cytoplasmic extracts were
prepared by NP-40 detergent lysis (Chang and Jacobs,
1993).
For secretory protein analysis, cell monolayers were
infected at an MOI = 5 and starved for methionine
0.5 h before radiolabelling. Cells were radiolabelled with
50 ACi of [35S]methionine/ml (800 Ci/mmol) from 3–6 and
9–12 HPI. At the end of the labelling period, 1 ml of culture
media was harvested, centrifuged at 2000  g for 10 min,
and the supernatant transferred to a fresh tube. The super-
natant was brought to 10% trichloracetic acid, incubated at 4
jC for 5 min, and centrifuged at 15000  g for 30 min. The
pellet was resuspended in 50 Al 1 M Tris, pH 10.0, total
protein concentration determined by BCA analysis, and
equal protein amounts were analyzed by SDS-PAGE.
Radiolabelled proteins were visualized by autoradiography.
RNA degradation assay
The level of ribosomal RNA degradation was determined
by isolating total RNA from infected cells at 12 or 18 HPI.
Cells (4  106 cells) were scraped into the media and
washed once in PBS. The cell pellet was resuspended in 1
ml of a 1:1 solution containing RNase-free Tris-buffered
saline (TBS) pH 7.0 and 25:24:1 phenol/chloroform/isoamyl
alcohol. The mixture was immediately vortexed for 1 min
and centrifuged at 10000  g for 5 min. The aqueous phase
(400 Al) was transferred to a fresh tube and then 40 Al of 3
M sodium acetate pH 5.2 and 1 ml 100% ethanol was
added. The RNA was precipitated at 80 jC for 30 min
followed by centrifugation at 10000  g for 30 min. The
RNA pellets were resuspended in 20 Al 0.5% SDS and
quantified. Forty micrograms ethidium bromide/ml was
added to the RNA (10 Ag) that was then separated on a
1.8% agarose formaldehyde gel (Langland and Jacobs,
2002).
Levels of eIF-2a phosphorylation and intracellular VCP
Subconfluent cell monolayers were infected at an MOI =
5. At the indicated times postinfection, RIPA cell lysates
were prepared. Briefly, cells were scraped into the media
and pelleted at 500  g for 5 min. The cell pellet was
resuspended in RIPA lysis buffer (1 PBS, 1% NP-40,
0.5% sodium deoxycholate, 0.1% SDS, 100 mM NaF; 100
Al per 4  106 cells) and incubated on ice for 10 min. The
lysate was centrifuged at 10000  g for 10 min and the
supernatant transferred to a new tube. An equal volume of 2
 SDS sample buffer was added to the supernatant. The
samples were boiled and 30 Al was analyzed on a 12%polyacrylamide mini-gel. Separated proteins were trans-
ferred to nitrocellulose using a CAPS transfer buffer (20
mM CAPS pH 11.0, 20% methanol). The nitrocellulose was
blocked with BLOTTO (20 mM Tris pH 7.5, 120 mM NaCl,
3% nonfat dry milk). The blot was probed with rabbit anti-
phosphorylated eIF2a (1:1000 dilution; Research Genetics)
or rabbit anti-VCP (1:2000 dilution; Dr. S. Isaacs, Depart-
ment of Pathology and Laboratory Medicine, University of
Pennsylvania) for 18 h. Secondary goat anti-rabbit IgG
conjugated with horseradish peroxidase (1:5000) was added
followed by chemiluminescent development and autoradi-
ography. All extracts were also probed by Western blot with
goat anti-eIF2a (Santa Cruz Biochemicals) to confirm equal
amounts of the protein (data not shown) and to determine
the relative ratio of phosphorylated eIF2a to total eIF2a.
Virus growth curve
Indicated cell monolayers were infected at an MOI = 5.
At 1 h postinfection (HPI), the inoculum was removed, the
monolayer washed 2 times with PBS, and the media
replaced. Duplicate monolayers were infected to represent
harvests at 0 and 30 HPI. The 0 HPI monolayers were
harvested after the 1-h infection process. Culture super-
natants were harvested to measure extracellular virus re-
lease. The media was collected, centrifuged at 2000  g for
10 min, and the supernatant tittered. Cell monolayers were
harvested to measure intracellular virus levels. At the
indicated times, monolayers were washed 3 times with
media followed by scraping the cells off the dish and into
media. The virus was released from cells by three cycles of
freeze–thawing. Virus titers were obtained by plaquing in
RK13 cells that have previously been shown to be permis-
sive for all viruses used in this study (Shors et al., 1997).
Levels of PKR and PERK phosphorylation
Subconfluent cell monolayers in 100-mm dishes were
radiolabelled with 200 ACi [32P]orthophosphate/ml (9000
Ci/mmol) in phosphate-free MEM containing 1 mM
HEPES, pH 7.5 and 2% dialyzed FBS. Cells were
radiolabelled for 2 h followed by infection with the
indicated viruses at an MOI = 5. At 12 HPI, monolayers
were harvested and RIPA lysates prepared in the presence
of 10 mM tetrasodium pyrophosphate, 100 mM NaF,
17.5 mM h-glycerophosphate, 1 mM PMSF, 4 Ag apro-
tinin/ml, and 2 Ag pepstatin A/ml. Radiolabelled lysates
were incubated 16 h with anti-PERK (Dr. D. Ron, New
York University School of Medicine) or anti-PKR (1:1
mixture: BD Transduction Laboratory anti-p68 kinase and
Cell Signaling PKR antibody) followed by precipitation
with protein A-agarose (Sigma). The immune precipitate
was separated by SDS-PAGE and analyzed by autoradi-
ography. As a control for PERK activation, wtVV-
infected cells were treated with 100 nM thapsigargin
(Sigma) for 0.5 h before harvest.
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C57BL/6 mice, 4 weeks of age, were anaesthetized using
a cocktail containing 7.5 mg/ml xylazine (Phoenix Pharma-
ceuticals, St. Joseph, MO), 2.5 mg/ml acepromazine male-
ate, and 37.5 mg/ml ketamine (Fort Dodge Laboratories,
Fort Dodge, IA) at the rate of 1 Al/gm body weight of mice
administered by intramuscular injection. Duplicate mice
were then infected with 106 plaque forming units (pfu) of
each virus in 1 mM Tris HCl pH 8.8 by intranasal route
(10 Al total volume). Animals were euthanized 5 days
postinfection using an overdose of halothane. The nasal
turbinates were harvested and quick-frozen using liquid
nitrogen. The tissue samples were weighed, ground to a
fine powder in liquid nitrogen, and resuspended in 2.5
volumes RIPA lysis buffer (1 PBS, 1% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS, 100 mM NaF). The lysate
was incubated on ice for 10 min, centrifuged at 10000  g
for 10 min, and the supernatant transferred to a new tube.
Protein concentrations were determined by BCA analysis
and equal protein amounts were separated on SDS-PAGE
and analyzed by Western blot using rabbit anti-phosphory-
lated eIF2a (1:1000 dilution; Research Genetics).Acknowledgments
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